New hope for Tough-to-Treat colon cancer: trial tests promising drug duos
NCT ID NCT07286695
Summary
This study compares two different drug combinations for people with advanced colorectal cancer that has spread and no longer responds to standard chemotherapy. Researchers want to see whether adding fruquintinib or bevacizumab to the chemotherapy drug trifluridine/tipiracil works better to control the cancer and is safer. The trial will enroll about 292 adults whose cancer progressed after at least two prior treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100000, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.